Skip to content

Get Judicial Watch Updates!

DONATE

Judicial Watch • Nigeria

Nigeria

Nigeria

Page 1: Nigeria

Category:

Number of Pages:41

Date Created:January 4, 2019

Date Uploaded to the Library:January 15, 2019

Tags:Nigeria, Assist, Commons, Submission, funding, grants, award, application, research, Budget, project, health, policy, HHS, federal


File Scanned for Malware

Donate now to keep these documents public!


See Generated Text   ∨

Autogenerated text from PDF

Centers for Disease Control
Center for Global Health Extramural Research Program Office
Advancing Infectious Disease Detection and Response Nigeria
RFA-GH-19-010
Application Due Date: 03/04/2019
Advancing Infectious Disease Detection and Response Nigeria
RFA-GH-19-010
TABLE CONTENTS
Part Overview Information
Key Dates
Required Application Instructions
Executive Summary
Part Full Text
Section Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
Part Overview Information
Participating Organization(s)
Centers for Disease Control
Components Participating Organizations
Center for Global Health Extramural Research Program Office (CGH ERPO)
Center for Global Health (CGH)
Notice Funding Opportunity (NOFO) Title
Advancing Infectious Disease Detection and Response Nigeria
Activity Code
U01- Cooperative Agreement
Notice Funding Opportunity Type
New
Agency Notice Funding Opportunity Number
RFA-GH-19-010
Assistance Listings (CFDA) Number(s)
93.326
Category Funding Activity:
Health
NOFO Purpose
The purpose this Notice Funding Opportunity (NOFO) conduct high quality public
health research. Research projects may quantitative, qualitative, and /or mixed methods
epidemiological studies conduct and monitor epidemiologic, clinical, and laboratory-based
projects, surveillance, and research important diseases Nigeria, including but not limited
address acute febrile illness, emerging and re-emerging infectious diseases, zoonotic and vector
borne diseases; environmental health issues effecting infectious diseases (such water and air);
vaccine-preventable diseases; biosafety and security; and other public health threats local
importance.
Research projects should outline clear plans incorporate the results research activities into
operational disease detection, prevention, and response control programs Nigeria and
ensure the strengthening local workforce capacity and dissemination findings across the
region, with partners, and globally.
Other areas for research include activities antimicrobial resistance and hospital acquired
infections, respiratory infections and influenza, enteric illnesses, and other public health threats.
Key Dates
Publication Date: receive notification any changes RFA-GH-19-010, return the
synopsis page this announcement
www.grants.gov and click the
Send Change Notification
Emails link. email address
Letter Intent Due Date:
N/A
Application Due Date:
needed for this service.
N/A
03/04/2019
On-time submission requires that electronic applications error-free and made available
CDC for processing from the NIH eRA system before the deadline date. Applications
must submitted and validated successfully Grants.gov later than 5:00 U.S.
Eastern Time. Applications must submitted using the Application Submission System
Interface for Submission Tracking (ASSIST) module which web-based service used for the
preparation and submission grant applications CDC through Grants.gov. ASSIST provides
the ability for applicants prepare their applications online, and offers the applicant additional
capabilities including the ability preview the application image, validate the application
against required business rules, and prepopulate data from applicant organizations records,
therefore identifying issues earlier the application submission process.
Note: HHS/CDC grant submission procedures not provide grace period beyond the
application due date time correct any error warning notices noncompliance with
application instructions that are identified Grants.gov eRA systems (i.e., error correction
window).
Scientific Merit Review:
04/23/2019
Secondary Review:
05/29/2019
Estimated Start Date:
09/30/2019
Expiration Date:
Due Dates for E.O. 12372:
03/05/2019
Executive Order 12372 does not apply this program.
Required Application Instructions
**ELECTRONIC APPLICATION SUBMISSION VIA ASSIST PREFERRED** recommended that applicants use ASSIST for the electronic preparation and submission
applications through Grants.gov CDC. ASSIST alternative method prepare and
submit applications, and provides many features facilitate the application submission process
which improves data quality (e.g., pre-population organization data, pre-submission
validation business rules, and preview the application image used for review). Use the
Grants.gov downloadable Adobe application packages and submission process will still
supported. critical that applicants follow the instructions the 424 (RR) Application Guide
except where instructed otherwise this NOFO. Conformance all requirements (both the Application Guide and the NOFO) required and strictly enforced. Applicants must read
and follow all application instructions the Application Guide well any program-specific
instructions noted Section IV. When the program-specific instructions deviate from those
the Application Guide, follow the program-specific instructions.
Note: The Research Strategy component the Research Plan limited pages.
Applications that not comply with these instructions may delayed not accepted
for review.
Telecommunications for the Hearing Impaired: TTY 1-888-232-6348
Note: The Research Strategy component the Research Plan limited pages per
project
Executive Summary
Purpose:
The purpose this Notice Funding Opportunity (NOFO) conduct high quality public
health research. Research projects may quantitative, qualitative, and /or mixed methods
epidemiological studies conduct and monitor epidemiologic, clinical, and laboratory-based
projects, surveillance, and research important diseases Nigeria, including but not limited
address acute febrile illness, emerging and re-emerging infectious diseases, zoonotic and vector
borne diseases; environmental health issues effecting infectious diseases (such water and air);
vaccine-preventable diseases; biosafety and security; and other public health threats local
importance.
Research projects should outline clear plans incorporate the results research activities into
operational disease detection, prevention, and response control programs Nigeria and
ensure the strengthening local workforce capacity and dissemination findings across the
region, with partners, and globally.
Other areas for research include activities antimicrobial resistance and hospital acquired
infections, respiratory infections and influenza, enteric illnesses, and other public health threats.
Mechanism Support: Cooperative Agreement
Funds Available and Anticipated Number Awards. The estimated total level
funding (in U.S. dollars) available, including direct and in-direct costs, for entire 5-year
project period $5,000,000. The number awards will (one). Awards issued
under this NOFO are contingent upon availability funds and sufficient meritorious
application. Because the nature and scope the proposed research will vary from
application application, also anticipated that the size and duration each award
may also vary. The total amount awarded and the number awards will depend upon
the number, quality, duration and cost the applications received.
Budget and Period Performance. The budget period anticipated run from
09/30/2019 09/29/2020. The project period anticipated run from 09/30/2019
09/29/2024. The estimated total funding (direct and indirect) for the first budget period
9/30/2019 9/29/2020, estimated range from USD $1,000,000 USD.. The
estimated total funding (direct and indirect) for the entire period performance;
9/30/2019 9/29/2024 estimated $5,000,000 USD.
Application Research Strategy Length: Page limits for the Application Research
Strategy specified Section IV. Application and Submission Information this
announcement.
Eligible Institutions/Organizations: Institutions/organizations listed Section III.1
are eligible apply.
Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the
skills, knowledge, and resources necessary carry out the proposed research are invited work with their institution/organization develop application for support. NOTE:
CDC does not make awards individuals directly. Individuals from underrepresented
racial and ethnic groups well individuals with disabilities are always encouraged
apply.
Number PDs/PIs: There will only one (1) qualified PD/PI for each application.
Number Applications: Only one (1) application per eligible institution (normally
identified unique DUNS number) allowed.
Application Type: New
Special Date(s): Application due date 2/21/2019
Application Materials: See Section IV.1 for application materials.
Hearing Impaired: Telecommunications for the hearing impaired are available at:
TTY: 1-888-232-6348.
Part Full Text
Section Funding Opportunity Description
Statutory Authority
307 U.S.C. Sections 242 and 317(k) (2) the Public Health Service Act, U.S.C. Sections
241(a) and 247b (k) (2), amended Background and Purpose
While CDC has worked Nigeria for decades (mostly areas like smallpox eradication
nutrition), the agency established permanent country office Abuja February 2001. With
the establishment the U.S. President Emergency Plan for AIDS Relief (PEPFAR) 2004,
CDC presence Nigeria greatly expanded. 2017, Nigeria signed the Global Health Security Agenda (GHSA) following its agreement
meet obligations under the International Health Regulations 2005. CDC works with the
Government Nigeria and other partners achieve these requirements focusing
workforce development, emergency response, surveillance, laboratory, and border health/point entry interventions. CDC supports efforts protect the public health developing and
strengthening health systems Nigeria providing technical leadership rapidly respond
disease outbreaks and emerging infectious diseases.
Outbreak prevention and global health security considerations are priority international
health strategy and for CDC Nigeria. During the West African Ebola outbreak, there were
laboratory-confirmed and one probable Ebola cases two states Nigeria (the most populous
country Africa) after very sick traveler from Liberia arrived the international airport
Lagos July 2014. the time was recognized that the patient carried the Ebola virus, the
traveler had exposed people the aircraft, airport, and hospital. appeared that
conditions were ripe for the disease spread through the city and the nation. result
quick action Nigerian authorities, CDC, team international partners, and the activation Ebola Incident Management Center precursor Nigeria current Emergency
Operations Center) the virus was contained within few weeks. With this new research
cooperative agreement, CDC strives continue supporting global health security work
Nigeria generating evidence-based data for public health action.
Healthy People 2020 and other National Strategic Priorities
While Healthy People 2020 goals are generally specific domestic programs, the global
health activities within this NOFO extends the national strategic priorities. Ensuring Global
Health Security national strategic priority, especially GHSA countries and Ebola-affected
and related countries. Nigeria priority country for CDC and for the Defense Threat
Reduction Agency. The NSC currently reassessing biologic risk profiles; this time there decision GHSA strategic priorities for 2020-2025 but irrespective final priority listings
Nigeria remains GHS focus high concern.
The Department Health and Human Services (HHS) Global Health Strategy maintains three
goals support HHS global health vision healthier, safer world: protect and promote
the health and well-being Americans through global health action; provide leadership and
technical expertise science, policy, programs and practice improve global health; and
advance United States interests international diplomacy, development, and security through
global health action.
Public Health Impact
The intention the NOFO provide global health security impact through conducting
public health research infectious diseases that can guide stakeholders prioritize resources
and implement health practices and policies mitigate the impact the local and international
ramifications health threats. Through better understanding disease threats, and their control
and prevention, morbidity and mortality may lowered, and global health security increased.
More importantly, the development research partners other countries can accomplished
through Cooperative Agreement mentoring and support.
The proposed public health research will used understand the data and help define
national and sub-national health policies. This allows for the appropriate allocation resources
and the ability implement public health interventions for controlling infectious diseases the
community. The goal use these data identify potential disease outbreaks and guide
clinical treatment, ensure coordinated linkages between the public health leadership and referral
laboratories identify and respond emerging/unknown pathogens, and ensure sustainability tiered surveillance and laboratory system.
Relevant Work
CDC has worked Nigeria with the Federal Ministry Health (FmoH) since 2004. The
FMoH the parent organization the Nigeria Center for Disease Control (NCDC). The goal the work develop and strengthen systems enable the identification and response
emerging and re-emerging infections. CDC coordinates with local, regional, and global public
health entities rapidly detect, accurately identify, and promptly contain emerging disease
threats. Collaborations with partners are essential generate important data the burden
broad range infectious diseases, detection poorly understood and novel pathogens, well causes and rates mortality the populations under surveillance. The collaborations result the strengthening public health capacity within Ministries Health (MOHs) and
Ministries Agriculture (MoAg) primarily collaboration with Departments Epidemiology
and Surveillance, the National Laboratories, the National Public Health Institutes, and other
specific disease control programs. the last years, NCDC has successfully moved IHR engagement from inactivity Joint
External Evaluation and national action plan development and implementation. has built
Emergency Operations Center that activated times year, and then added Incident
Command Center handle overflow activity associated with the dozens investigations and
local responses. has, with the assistance partners, deployed electronic Integrated Disease
Surveillance and Response reporting and introduced electronic case management reporting
the states most effected outbreaks. has built national reference lab and developed
National Reference Laboratory capability, and forging network labs and sample
transport. has also led promoted advances Infection Prevention and Control, medical
countermeasures and supply chain logistics.
CDC has several activities that support relate specifically this NOFO. Prospective
applicants should refer the following websites and related documents for additional
information:
http://www.cdc.gov/globalhealth
https://www.cdc.gov/globalhealth/healthprotection/ghs/index.html
http://www.cdc.gov/globalhealth/ihregulations.htm
http://www.cdc.gov/globalhealth/ghi Approach
Objectives/Outcomes
Applicants may propose three projects the first year award that support develop
public health related research activities and studies. Projects should focused the
detection, prevention, response, and elimination communicable diseases, zoonosis, and other
emerging and re-emerging public health threats Nigeria.
Disease Areas
Applicants may focus their application one more the following eligible disease areas: Acute febrile illness (AFI) High priority diseases such meningitis viral hemorrhagic fevers Zoonoses and emerging diseases Antimicrobial resistance (AMR) and/or healthcare-associated infections (HAI) (i.e.
nosocomial hospital acquired infections) Respiratory illness and influenza Enteric illnesses One Health research Other public health issues regional and local importance
RESEARCH CATEGORIES
Applicants must propose projects that focus the disease area(s) selected least one the
following research categories. the first year award, applicants may only submit three
projects total. All three projects can proposed one research category can
combination the three categories: Examples projects are provided under each
research category:
Project Category Characterize Public Health Threats
Includes conducting research activities identify modifiable risk factors for priority diseases
through community and/or population-based observational research. Also included are research disease burden, transmission other factors related risk. Research findings should
presented international meetings and published the peer-reviewed literature.
Examples projects that characterize public health threats are:
Develop, maintain, expand one more surveillance systems Nigeria, combining
population-based and facility-based surveillance designed determine burden disease,
transmission dynamics, risk factors, relative contribution different pathogens disease
syndromes, and control infectious agents. multi-site system could include population/site
diversity with regard urban/rural, socioeconomic factors, etc.
Support the development strengthening laboratories and/or platforms used for etiologic
investigation, evaluation novel diagnostic assays for faster and easier detection, and
characterization pathogens.
Develop and/or maintain one more research sites investigate and report the interactions
between specific pathogens and underlying comorbidities.
Conduct ongoing and systematic collection, analysis and interpretation biological samples
and data for both animal and human health collaboration with Ministries Health and
Agriculture Nigeria order strengthen surveillance national and regional levels.
Conduct research the human-animal interface zoonotic diseases and risks transmission
from animals humans.
Provide innovative solutions identified through research develop early warning systems
report sentinel organisms humans that can serve alert for multidrug resistant organisms
and interventions for adequate antimicrobials
Project Category Determine Most Effective Implementation Approaches:
Includes research the most effective implementation approaches for responding global
public health threats and building global health security capacity.
Examples projects that address effective implementation approaches are:
Conduct qualitative socio-cultural research and surveys knowledge, attitudes, and practices
related infectious disease and the acceptance interventions and prevention methods.
Develop cost disease estimates and cost effectiveness estimates for priority diseases.
Develop processes for collecting and analyzing information the costs associated with
surveillance and research activities and the potential savings the population level early
detection and control.
Project Category Measuring Impact
Includes research interventions prevent and control diseases importance. These projects
might use various designs and sources data. The findings should used guide the
development and/or improvement national and regional policies and programs for disease
prevention, monitoring and control.
Examples projects that measure impact are:
Conduct evaluations surveillance programs Nigeria determine coverage rates, barriers,
best practices, and effectiveness.
Conduct research assess efficacy/effectiveness, immunogenicity and impact vaccines,
treatments, and non-pharmaceutical interventions and other control measures reduce the
burden influenza disease among vulnerable populations.
Conduct systematic review AMR/HAI activities Nigeria. This includes the
development catalogue research and public institutions working AMR/HAI include
information location, description activities, populations served, and summary relevant
publications the last years.
Conduct research estimate the direct and indirect costs, and document the economic burden priority diseases and interventions.
Studies measure the impact enhancements public health surveillance country (in
terms outbreaks controlled, cases averted, time lags from specimen detection collection
etc.).
Target Population
The prospective applicant must identify the target populations addressed through this
NOFO, including risk factors for disease and impact increased diagnostics and surveillance population type. The prospective applicant should use data generated under this NOFO
identify communities disproportionately affected different infectious diseases, and propose
activities/interventions reduce eliminate these disparities. The applicant should describe
how the activities under this NOFO will inclusive all affected populations.
Collaboration/Partnerships
Nigeria CDC the national focal point for the International Health Regulations and GHSA. the hub through which other ministries and agencies and the federated States
coordinate their work. Post JEE and GHSA activity has triggered large coalition partners,
including Public Health England and DFID, Robert Koch Institute and GIZ, Japan International
Cooperation Agency, and Gates Foundation, name few. WHO has longstanding
relationship with NCDC and the FMoH. The World Bank REDISSE program, through
ECOWAS and WAHO, has partnered with NCDC implement global health security
activities. Through this cooperative agreement, NCDC will build upon the existing programs
established these partners and ensure comprehensive approach global health security
Nigeria.
Evaluation/Performance Measurement part the application, the should include measurable goals and aims based 5-year
research project period. The applicant will establish specific, measurable, achievable, realistic
and time-phased (SMART) project objectives for each activity described the applicant
project plan, and develop and implement project performance measures that are based
specific programmatic objectives.
Monitoring and Evaluation
Work with CDC and other global partners appropriate develop and implement
evaluation plan measure the impact the activities outlined this funding opportunity
announcement (evaluation framework, evaluation design, indicators, process and outcome
evaluation, and information/data collection plan).
Program Capacity
Establish retain full-time staff person with management and technical experience,
responsible for managing the planning, implementation, and evaluation the program and
serving the CDC point contact. Establish retain part-time staff person with data
management and mobile data collection experience responsible for the programming and
trouble-shooting data collection instruments, cleaning data, development data
dictionaries and storage datasets. Establish retain additional staff with demonstrated
knowledge, skills, and expertise administrative and fiscal management meet the needs
the program. Over the course the project period establish and retain other staff, contractors,
and consultants sufficient number and expertise ensure project success.
Fiscal management
Programs must use funding support activities alignment with requirements this NOFO.
Programs must develop and maintain systems for sound fiscal management, including:
monitoring the cooperative agreement award and program contracts and grants, ensuring the
funds are expended support approved activities.
Translation Plan
The applicant should describe plans for how research and scientific findings will reported
and disseminated (e.g., peer-reviewed journals, scientific presentations, reports, meetings and
conferences) and specify how these activities are integrated into the project plans. The
translation findings should understandable variety audiences, including policy
makers, practitioners, public health programs, health care institutions, professional
organizations, community groups, researchers, and other potential users.
Questions consider preparing this section include: How will the scientific findings inform the government Nigeria well other
stakeholders needed public health policies practices the local and national level? How will the research project improve affect the translation study findings into policy practice? How will the research findings help promote accelerate the dissemination, implementation, diffusion improvements public health programs and practices? How will the research findings advance guide future scientific efforts related activities? How will the research activities improve public health outcomes, advance workforce
development, and enhance response capacity?
Application Approach
The applicant should submit one overall research proposal response this application, which
may include more than three projects part the first year award proposal. The proposal
may include epidemiologic projects, laboratory-based projects, evaluation interventions and
control methods including therapeutic and preventative treatments. Projects can focus
multiple infectious disease syndrome(s) group diseases that are clinically functionally
related, identifiable public health concern problem affecting health Nigeria. Projects
may new activities for the applicant may aimed continuing and enhancing ongoing
activities addressing public health concerns Nigeria.
The applicant should submit separate research plan and budget for each proposed project
within the proposal. more than three research plans and budgets should submitted for the
first year award proposal.
The research plans should not exceed pages per project. The research plan for each proposed
project should address administrative tasks and oversight for the project well coordination research objectives with other projects appropriate. Please note CDC prefers not receive
one project cover all administrative tasks and costs but instead appropriate administrative
tasks and costs should included each project budge
Section II. Award Information
Funding Instrument Type:
Cooperative Agreement support mechanism used when there
will substantial Federal scientific
programmatic involvement. Substantial
involvement means that, after award,
scientific program staff will assist,
guide, coordinate, participate
project activities.
Application Types Allowed:
New application that submitted for funding for the first time. Includes multiple
submission attempts within the same round.
Estimated Total Funding:
$5,000,000
Anticipated Number Awards:
Awards issued under this NOFO are contingent the availability funds and submission
sufficient number meritorious applications.
Award Ceiling:
$1,000,000 Per Budget Period
Award Floor: Per Budget Period
Total Period Performance Length: year(s)
Throughout the Period Performance, CDCs commitment continuation awards will
depend the availability funds, evidence satisfactory progress the recipient (as
documented required reports), and CDC determination that continued funding the best
interest the Federal government.
HHS/CDC grants policies described the HHS Grants Policy Statement
(http://www.hhs.gov/ sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf) will
apply the applications submitted and awards made response this NOFO.
Section III. Eligibility Information Eligible Applicants
Eligibility Category:
Others (see text field entitled Additional
Information Eligibility for clarification)
Additional Eligibility Category: Foreign Organizations
Foreign Organizations are eligible apply.
Foreign (non-US) organizations must follow policies described the HHS Grants Policy
Statement (http://www.hhs.gov/asfr/ogapa/aboutog/hhsgps107.pdf), and procedures for foreign
organizations described throughout the SF424 (RR) Application Guide. International
registrants can confirm DUNS sending e-mail ccrhelp@dnb.com, including Company
Name, D-U-N-S Number, and Physical Address, and Country. Special Instructions for acquiring Commercial and Governmental Entity (NCAGE) Code: https://eportal.nspa.nato.int/AC135
Public/Docs/US%20Instructions%20for%20NSPA%20NCAGE.pdf.
Foreign components U.S. Organizations are eligible apply.
For this announcement, applicants may include collaborators consultants from foreign
institutions. All applicable federal laws and policies apply. Special Eligibility Requirements
Foreign Organizations are eligible apply.
Foreign (non-US) organizations must follow policies described the HHS Grants Policy
Statement (http://www.hhs.gov/asfr/ogapa/aboutog/hhsgps107.pdf), and procedures for foreign
organizations described throughout the SF424 (RR) Application Guide. International
registrants can confirm DUNS sending e-mail ccrhelp@dnb.com, including Company
Name, D-U-N-S Number, and Physical Address, and Country. Special Instructions for acquiring Commercial and Governmental Entity (NCAGE) Code:
https://eportal.nspa.nato.int/AC135Public/Docs/US%20Instructions%20for%20NSPA%20NCA
GE.pdf
Additional Information Eligibility
Single source competition. Only the application from Nigeria Centre for Disease Control will
accepted. Justification for Less than Maximum Competition
Nigeria CDC the National Public Health Institute for Nigeria and the government parastatal
organization under the MoH, which charged with prevention, detection and response
infectious disease outbreaks. NCDC the sole entity with government mandate manage data
that includes disease specific information multiple priority diseases prevent and control
outbreaks; other organization has the breadth and depth data. NCDC also charged with
coordinating the implementation the International Health Regulations.NCDC mandated
research functions are based U.S. CDC research functions, and therefore the only candidate
with which CDC can develop the governments ability research emerging diseases the
context outbreak prevention. The NCDC focus for epidemiological expertise Nigeria
supported the FETP program, which provides ready access 100 advanced fellows
training, well access the professors the Nigerian universities that sponsor the
program and the network graduates the program.The NCDC leads responses outbreaks
well smaller investigations. This level direct engagement with the partners interest not
available through any other entity. The NCDC manages the two functional Nigerian National
Reference Labs Abuja and Lagos. These laboratories have alliterative equivalent Nigeria.
The laboratory the influenza lab, the repository the 170,000 sample NEISS HIV study,
CDC-supported mega-lab, and key PCR facility for testing Lymphatic Filariasis, Yellow
Fever, measles, meningitis and monkeypox.The goal this NOFO both develop research
capability and investigate characteristics the current priority pathogens and matched
interventions. With this mandate, NCDC the only entity within Nigeria with which CDC can
partner sustainable, capacity building approach public health research. Without this
mechanism, NCDC and CDC will unable generate the data needed implement evidencebased public health research projects better characterize disease threats, determine the most
effective implementation approaches and measure impact. Responsiveness
N/A Required Registrations
Applicant organizations must complete the following registrations described the 424
(RR) Application Guide eligible apply for receive award. Applicants must have
valid Dun and Bradstreet Universal Numbering System (DUNS) number order begin each the following registrations.
(Foreign entities only): Special Instructions for acquiring Commercial and
Governmental Entity (NCAGE) Code: https:// eportal.nspa.nato. int/ AC135Public/ Docs/
US%20Instructions%2 0for%20NSPA%20NCAGE.pdf
System for Award Management (SAM) must maintain current registration SAM (the
replacement system for the Central Contractor Registration) renewed
annually, https://www.sam.gov/portal/SAM/.
Grants.gov
eRA Commons
All applicant organizations must register with Grants.gov. Please visit www.Grants.gov least days prior submitting your application familiarize yourself with the registration and
submission processes. The one-time registration process will take three five days
complete. However, best start the registration process least two weeks prior
application submission.
All Program Directors/Principal Investigators (PD/PIs) must also work with their institutional
officials register with the eRA Commons ensure their existing Principle Investigator
(PD/PI) eRA Commons account affiliated with the eRA commons account the applicant
organization. All registrations must successfully completed and active before the application
due date. Applicant organizations are strongly encouraged start the eRA Commons registration
process least four (4) weeks prior the application due date. ASSIST requires that applicant
users have active eRA Commons account order prepare application. also requires that
the applicant organizations Signing Official have active eRA Commons Signing Official
account order initiate the submission process. During the submission process, ASSIST will
prompt the Signing Official enter their Grants.gov Authorized Organizational Representative
(AOR) credentials order complete the submission, therefore the applicant organization must
ensure that their Grants.gov AOR credentials are active. Universal Identifier Requirements and System for Award Management (SAM)
All applicant organizations must obtain DUN and Bradstreet (DB) Data Universal
Numbering System (DUNS) number the Universal Identifier when applying for Federal grants cooperative agreements. The DUNS number nine-digit number assigned Dun and
Bradstreet Information Services. AOR should consulted determine the appropriate
number. the organization does not have DUNS number, AOR should complete the
DB D-U-N-S Number Request Web Form contact Dun and Bradstreet telephone directly 1-866-705-5711 (toll-free) obtain one. DUNS number will provided immediately
telephone charge. Note this organizational number. Individual Program
Directors/Principal Investigators not need register for DUNS number.
Additionally, all applicant organizations must register the System for Award Management
(SAM). Organizations must maintain the registration with current information all times during
which has application under consideration for funding CDC and, award made,
until final financial report submitted the final payment received, whichever later.
SAM the primary registrant database for the Federal government and the repository into
which entity must provide information required for the conduct business recipient.
Additional information about registration procedures may found the SAM internet site https://www.sam.gov/index.html. award granted, the recipient organization must notify potential sub-recipients that
organization may receive subaward under the grant unless the organization has provided its
DUNS number the recipient organization. Eligible Individuals (Project Director/Principal Investigator)
Organizations/Institutions
Any individual(s) with the skills, knowledge, and resources necessary carry out the proposed
research the Project Director/Principal Investigator (PD/PI) invited work with his/her
organization develop application for support. Individuals from underrepresented racial and
ethnic groups well individuals with disabilities are always encouraged apply for
HHS/CDC support. Cost Sharing
This FOA does not require cost sharing defined the HHS Grants Policy Statement
(http://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf).
10. Number Applications defined the HHS Grants Policy Statement,
(https://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf),
applications received response the same Notice Funding Opportunity generally are scored
individually and then ranked with other applications under peer review their order relative
programmatic, technical, scientific merit. HHS/CDC will not accept any application
response this NOFO that essentially the same one currently pending initial peer review
unless the applicant withdraws the pending application.
Applicant organizations may submit only one application.
Section IV. Application and Submission Information Address Request Application Package order use ASSIST, applicants must visit https://public.era.nih.gov/assist where you can
login using your eRA Commons credentials, and enter the Notice Funding Opportunity
Number initiate the application, and begin the application preparation process. you experience problems accessing using ASSIST, you can refer the ASSIST Online
Help Site at: https://era.nih.gov/erahelp/assist. Additional support available from the NIH
eRA Service desk via:
E-mail: http://grants.nih.gov/support/index.html
Phone: 301-402-7469 (toll-free) 1-866-504-9552. The NIH eRA Service desk available Monday Friday, a.m. p.m. Eastern Time, excluding federal
holidays. Content and Form Application Submission critical that applicants follow the instructions the SF-424 (RR) Application
Guide http://grants.nih.gov/grants/how-to-apply-application-guide.htm and
here: https://grants.nih.gov/grants/how-to-apply-application-guide/forms-e/general-forms-e.pdf,
except where instructed this Notice Funding Opportunity otherwise. Conformance
the requirements the Application Guide required and strictly enforced. Applications that
are out compliance with these instructions may delayed not accepted for review. The
package associated with this NOFO includes all applicable mandatory and optional forms.
Please note that some forms marked optional the application package are required for
submission applications for this NOFO. Follow the instructions the SF-424 (RR)
Application Guide ensure you complete all appropriate optional components.
When using ASSIST, all mandatory forms will appear separate tabs the top the
Application Information screen; applicants may add optional forms available for the NOFO
selecting the Add Optional Form button the left navigation panel.
Please include all the eight (8) mandatory forms listed below the application package:
Mandatory
SF424(RR)[V2.0];
PHS 398 Cover Page Supplement [V4.0];
Research and Related Other Project Information [V1.4];
Project/Performance Site Location(s) [V2.0];
Research and Related Senior/Key Person Profile (Expanded) [V2.0];
Research and Related Budget [V1.4];
PHS 398 Research Plan [V4.0];
PHS Human Subjects and Clinical Trials Information [V1.0].
Please include the one (1) optional form listed below, applicable, the application package:
Optional RR Subaward Budget Attachment(s) Form ATT. Letter Intent
Due Date for Letter Intent: [Insert days from date publication]
N/A Required and Optional Components complete application has many components, both required and optional. The forms package
associated with this NOFO Grants.gov includes all applicable components for this NOFO,
required and optional. ASSIST, all required and optional forms will appear separate tabs
the top the Application Information screen. PHS 398 Research Plan Component
The SF424 (RR) Application Guide includes instructions for applicants complete PHS 398 Research Plan that consists components. Not all components the Research Plan
apply all Notices Funding Opportunities (NOFOs). Specifically, some the following
components are for Resubmissions Revisions only. See the 424 (RR) Application
Guide https://grants.nih.gov/grants/how-to-apply-application-guide/forms-e/generalformse.pdf and https://apply07.grants.gov/apply/forms/sample/SF424B-V1.1.pdf for additional
information. Please attach applicable sections the following Research Plan components
directed Part Section (Notice Funding Opportunity Description).
Follow the page limits stated the 424 unless otherwise specified the NOFO.
applicable and specified the NOFO, the application should include the bolded headers
this section and should address activities conducted over the course the entire project,
including but not limited to: Introduction Application (for Resubmission and Revision ONLY) provide clear
description about the purpose the proposed research and how addresses the specific
requirements the NOFO. Specific Aims state the problem the proposed research addresses and how will
result public health impact and improvements population health. Research Strategy the research strategy should organized under headings:
Significance, Innovation and Approach. Describe the proposed research plan, including
staffing and time line. Progress Report Publication List (for Continuation ONLY)
Other Research Plan Sections Vertebrate Animals Select Agent Research Multiple PD/PI Leadership Plan. Consortium/Contractual Arrangements Letters Support
10. Resource Sharing Plan(s)
11. Authentication Key Biological and/or Chemical Resources
12. Appendix
All instructions the SF424 (RR) Application Guide https://grants.nih.gov/grants/how-toapply-application-guide/forms-e/general-forms-e.pdf and here:
https://apply07.grants.gov/apply/forms/sample/SF424B-V1.1.pdf must followed along with
any additional instructions provided the NOFO.
Applicants that plan collect public health data must submit Data Management Plan (DMP) the Resource Sharing Plan section the PHS 398 Research Plan Component the
application. DMP required for each collection public health data proposed. Applicants
who contend that the public health data they collect create are not appropriate for release
must justify that contention the DMP submitted with their application for CDC funds.
The DMP may outlined narrative format checklist but, minimum, should
include:
Descriptions the data produced the proposed project
How access will provided the data (including provisions for protection privacy,
confidentiality, security, intellectual property, other rights)
Use data standards that ensure all released data have appropriate documentation that
describes the method collection, what the data represent, and potential limitations for use
Plans for archival and long-term preservation the data, explaining why long-term
preservation and access cannot justified
Examples DMPs may found here: University California https://dmp.cdlib.org/, USGS, http://www.usgs.gov/datamanagement/plan/dmplans.php
Component (Inclusion Enrollment Report) applies only Renewal and Revision applications
for clinical research. Clinical research that which conducted with human subjects (or
material human origin such tissues, specimens and cognitive phenomena) for which
investigator (or colleague) directly interacts with human subjects. Excluded from this definition
are vitro studies that utilize human tissues that cannot linked living individual.
Patient-oriented research includes: (a) mechanisms human disease, (b) therapeutic
interventions, (c) clinical trials, and (d) development new technologies). Follow the page
limits the 424 unless otherwise specified the NOFO Appendix not use the appendix circumvent page limits. maximum PDF documents are
allowed the appendix. Additionally, publications may included that are
not publically available. Follow all instructions for the Appendix described the SF424
(RR) Application Guide. Page Limitations
All page limitations described this individual NOFO must followed. For this specific
NOFO, the Research Strategy component the Research Plan narrative limited pages.
Supporting materials for the Research Plan narrative included appendices may not exceed
PDF files with maximum 150 pages for all appendices. Format for Attachments
Designed maximize system-conducted validations, multiple separate attachments are required
for complete application. When the application received the agency, all submitted forms
and all separate attachments are combined into single document that used peer reviewers
and agency staff. Applicants should ensure that all attachments are uploaded the system.
CDC requires all text attachments the Adobe application forms submitted PDFs and that all text attachments conform the agency-specific formatting
requirements noted the SF424 (RR) Application
Guide https://grants.nih.gov/grants/how-to-apply-application-guide/forms-e/general-formse.pdf and here: https://apply07.grants.gov/apply/forms/sample/SF424B-V1.1.pdf. Submission Dates Times
Part Overview Information contains information about Key Dates. Applicants are strongly
encouraged allocate additional time and submit advance the deadline ensure they
have time make any corrections that might necessary for successful submission. This
includes the time necessary complete the application resubmission process that may
necessary, errors are identified during validation Grants.gov and the NIH eRA systems.
The application package not complete until has passed the Grants.gov and NIH eRA
Commons submission and validation processes.
Organizations must submit applications using the ASSIST web-based application preparation
and submission process.
ASSIST will validate applications before submission. the system detects errors, then the
applicant must correct errors before their application can submitted.
Applicants are responsible for viewing their application ASSIST after submission
ensure accurate and successful submission through Grants.gov. the submission not
successful and post-submission errors are found, then those errors must corrected and
the application resubmitted ASSIST.
Applicants are able access, view, and track the status their applications the eRA
Commons.
Information the submission process provided the SF-424 (RR) Application Guidance
and ASSIST User Guide https://era.nih.gov/files/ASSIST_user_guide.pdf.
Note: HHS/CDC grant submission procedures not provide grace period beyond the grant
application due date time correct any error warning notices noncompliance with
application instructions that are identified Grants.gov eRA systems (i.e. error correction
window).
Applicants who encounter problems when submitting their applications must attempt resolve
them contacting the NIH eRA Service desk at:
Toll-free: 1-866-504-9552; Phone: 301-402-7469
http://grants.nih.gov/support/index.html
Hours: Mon-Fri, a.m. p.m. Eastern Time (closed federal holidays)
Problems with Grants.gov can resolved contacting the Grants.gov Contact Center at:
Toll-free: 1-800-518-4726
https://www.grants.gov/web/grants/support.html
support@grants.gov
Hours: hours day, days week (closed federal holidays) the applicant encounters problems that prevent the ability submit application which
cannot resolved Grants.gov NIH eRA Service Desks, then applicants must contact
CDC Technical Information Management Section (TIMS) 770-488-2700; ogstims@cdc.gov
for guidance least calendar days before the deadline date. Therefore, important that
applicants complete the application submission process well advance the due date time.
After submission your application package, applicants will receive submission
receipt email generated Grants.gov. Grants.gov will then generate second e-mail
message applicants which will either validate reject their submitted application
package. third and final e-mail message generated once the applicants application
package has passed validation and the grantor agency has confirmed receipt the
application.
Unsuccessful Submissions: application submission was unsuccessful, the applicant must: Track submission and verify the submission status (tracking should done initially
regardless rejection success). the status states rejected, #2a #2b Check emails from both Grants.gov and NIH eRA Commons for rejection notices. the deadline has passed, he/she should email the Grants Management contact listed
the Agency Contacts section this announcement and ogstims@cdc.gov explaining why
the submission failed. there time before the deadline, correct the problem(s) and resubmit soon
possible.
Due Date for Applications: 03/04/2019
Electronically submitted applications must submitted later than 5:00 p.m., ET, the
listed application due date.
10. Intergovernmental Review (E.O. 12372)
This initiative not subject intergovernmental review (http:// www. whitehouse.gov/ omb/
grants_spoc).
11. Funding Restrictions
All HHS/CDC awards are subject the federal regulations, CFR 75, terms and conditions,
and other requirements described the HHS Grants Policy Statement. Pre-award costs may
allowable expanded authority, but only authorized CDC. accordance with the United States Protecting Life Global Health Assistance policy, all
non-governmental organization (NGO) applicants acknowledge that foreign NGOs that receive
funds provided through this award, either prime recipient subrecipient, are strictly
prohibited, regardless the source funds, from performing abortions method family
planning engaging any activity that promotes abortion method family planning, provide financial support any other foreign non-governmental organization that conducts
such activities. See Additional Requirement (AR) for applicability
(https://www.cdc.gov/grants/additionalrequirements/ar-35.html).
For more information expanded authority and pre-award costs,
to: https://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf.
CDC requires that mechanisms for, and cost of, public health data sharing included grants,
cooperative agreements, and contracts. The cost sharing archiving public health data may
also included part the total budget requested for first-time continuation awards.
Fulfilling the data-sharing requirement must documented Data Management Plan (DMP)
that developed during the project planning phase prior the initiation generating
collecting public health data and must included the Resource Sharing Plan(s) section
the PHS398 Research Plan Component the application.
Applicants who contend that the public health data they collect create are not appropriate for
release must justify that contention the DMP submitted with their application for CDC funds
(for example, privacy and confidentiality considerations, embargo issues).
Recipients who fail release public health data timely fashion will subject
procedures normally used address lack compliance (for example, reduction funding,
restriction funds, award termination) consistent with CFR 74.62 other authorities
appropriate. For further information, please
see: https://www.cdc.gov/grants/additionalrequirements/ar-25.html for revised AR-25.
The Office Management and Budget (OMB) requires that all projects which CDC staff
will provide technical assistance advice any information collections more people
that are planned conducted the awardee, all such information collections where CDC
staff will are approving, directing, conducting, managing, owning data must undergo
OMB project determinations CDC and might require OMB PRA clearance prior the start the project.
Recipients may only expend funds for reasonable program purposes, including personnel,
travel, supplies, and services, such contractual. The direct and primary recipient
cooperative agreement program must perform substantial role carrying out project
objectives and not merely serve conduit for award another party provider who
ineligible.
Reimbursement pre-award costs not allowed.
Indirect Costs will not paid (either directly through sub-award) organizations
located outside the territorial limits the United States international organizations
regardless their location.
All requests for funds contained the budget, shall stated U.S. dollars. Once
award made, CDC will not compensate foreign grantees for currency exchange
fluctuations through the issuance supplemental awards.
Foreign grantees are subject audit requirements specified CFR 74.26(d). nonFederal audit required, during the grantees fiscal year, the grantee expended total $500,000.00 more under one more HHS awards (as direct grantee and/or
sub-grantee). The grantee either may have (1) financial related audit (as defined the
Government Auditing Standards, GPO stock #020-000-00-265-4) particular award accordance with Government Auditing Standards, those case where the grantee
receives awards under only one HHS program; or, awards are received under multiple
HHS programs, financial related audit all HHS awards accordance with
Government Auditing Standards; (2) audit that meets the requirements contained OMB Circular A-133. fiscal Grantee Capability Assessment may required, prior post award, order review the applicant business management and fiscal capabilities regarding the
handling U.S. Federal funds research involves human subjects, funds will restricted until Federal Wide
Assurance (FWA) and Institutional Review Board Approvals (IRB) are place.
Projects, directed CDC staff and involve the collection information from
more individuals, and are funded grant/cooperative agreement, will subject
review and approval the Office Management and Budget (OMB) under the
Paperwork Reduction Act.The Office Management and Budget (OMB) requires that
all projects which CDC staff will provide technical assistance advice any
information collections more people that are planned conducted the
awardee, all such information collections where CDC staff will are approving,
directing, conducting, managing, owning data must undergo OMB project
determinations CDC and might require OMB PRA clearance prior the start the
project.
12. Other Submission Requirements and Information
Risk Assessment Questionnaire Requirement
CDC required conduct pre-award risk assessments determine the risk applicant poses meeting federal programmatic and administrative requirements taking into account issues
such financial instability, insufficient management systems, non-compliance with award
conditions, the charging unallowable costs, and inexperience. The risk assessment will
include evaluation the applicant CDC Risk Questionnaire, located
https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, well
review the applicant history all available systems; including OMB-designated
repositories government-wide eligibility and financial integrity systems (see CFR
75.205(a)), and other sources historical information. These systems include, but are not
limited to: FAPIIS (https://www.fapiis.gov/), including past performance federal contracts
per Duncan Hunter National Defense Authorization Act 2009; Not Pay list; and System
for Award Management (SAM) exclusions.
CDC requires all applicants complete the Risk Questionnaire, OMB Control Number 09201132 annually. This questionnaire, which located
https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, along with
supporting documentation must submitted with your application the closing date the
Notice Funding Opportunity Announcement. your organization has completed CDC
Risk Questionnaire within the past months the closing date this NOFO, then you must
submit copy that questionnaire, submit letter signed the authorized organization
representative include the original submission date, organization EIN and DUNS.
When uploading supporting documentation for the Risk Questionnaire into this application
package, clearly label the documents for easy identification the type documentation. For
example, copy Procurement policy submitted response the questionnaire may
labeled using the following format: Risk Questionnaire Supporting Documents Procurement
Policy.
Duplication Efforts
Applicants are responsible for reporting this application will result programmatic,
budgetary, commitment overlap with another application award (i.e. grant, cooperative
agreement, contract) submitted another funding source the same fiscal year.
Programmatic overlap occurs when (1) substantially the same project proposed more than
one application submitted two more funding sources for review and funding
consideration (2) specific objective and the project design for accomplishing the objective
are the same closely related two more applications awards, regardless the funding
source. Budgetary overlap occurs when duplicate equivalent budgetary items (e.g.,
equipment, salaries) are requested application but already are provided another source.
Commitment overlap occurs when individual time commitment exceeds 100 percent,
whether not salary support requested the application. Overlap, whether programmatic,
budgetary, commitment individual effort greater than 100 percent, not permitted.
Any overlap will resolved the CDC with the applicant and the PD/PI prior award.
Report Submission: The applicant must upload the report under Other Attachment Forms.
The document should labeled: Report Programmatic, Budgetary, and Commitment
Overlap.
Application Submission
Applications must submitted electronically following the instructions described the 424
(RR) Application Guide. PAPER APPLICATIONS WILL NOT ACCEPTED.
Applicants must complete all required registrations before the application due
date. Section III.6 Required Registrations contains information about registration.
For assistance with your electronic application for more information the electronic
submission process, visit Applying Electronically (http://grants.nih.gov/grants/guide /url_
redirect.htm? id=11144).
Important reminders:
All PD/PIs must include their eRA Commons the Credential field the Senior/Key
Person Profile Component the 424(RR) Application Package. Failure register
the Commons and include valid PD/PI Commons the credential field will prevent
the successful submission electronic application CDC.
The applicant organization must ensure that the DUNS number provides the
application the same number used the organization profile the eRA Commons and
for the System for Award Management (SAM). Additional information may found
the SF424 (RR) Application Guide. the applicant has FWA number, enter the 8-digit number. not enter the letters
FWA before the number. Project/Performance Site engaged research involving
human subjects, the applicant organization responsible for ensuring that the
Project/Performance Site operates under and appropriate Federal Wide Assurance for the
protection human subjects and complies with CFR Part and other CDC human
subject related policies described Part the 424 (RR) Application Guide and
the HHS Grants Policy Statement.
See more resources avoid common errors and submitting, tracking, and viewing
applications:
http://grants.nih.gov/grants/ElectronicReceipt/avoiding_errors.htm
http://grants.nih.gov/grants/ElectronicReceipt/submit_app.htm
https://era.nih.gov/files/ASSIST_user_guide.pdf
http://era.nih.gov/erahelp/ASSIST/
Upon receipt, applications will evaluated for completeness the CDC Office Grants
Services (OGS) and responsiveness OGS and the Center, Institute Office the CDC.
Applications that are incomplete and/or nonresponsive will not reviewed.
Section Application Review Information Criteria
Only the review criteria described below will considered the review process. part the
CDC mission (http:// www.cdc.gov/ about/ organization/ mission.htm), all applications
submitted the CDC support public health research are evaluated for scientific and
technical merit through the CDC peer review system.
Overall Impact
Reviewers will provide overall impact/priority score reflect their assessment the
likelihood for the project exert sustained, powerful influence the research field(s)
involved, consideration the following review criteria and additional review criteria (as
applicable for the project proposed).
Scored Review Criteria
Reviewers will consider each the review criteria below the determination scientific
merit, and give separate score for each. application does not need strong all
categories judged likely have major scientific impact. For example, project that its
nature not innovative may essential advance field.
Significance
Does the project address important problem critical barrier progress the field?
the aims the project are achieved, how will scientific knowledge, technical capability, and/or
clinical practice improved? How will successful completion the aims change the
concepts, methods, technologies, treatments, services, preventative interventions that drive
this field?
Investigator(s)
Are the PD/PIs, collaborators, and other researchers well suited the project? Have they
demonstrated ongoing record accomplishments that have advanced their field(s)? the
project collaborative multi-PD/PI, the investigators have complementary and
integrated expertise; are their leadership approach, governance and organizational structure
appropriate for the project?
Innovation
Does the application challenge and seek shift current research clinical practice paradigms utilizing novel theoretical concepts, approaches methodologies, instrumentation,
interventions? Are the concepts, approaches methodologies, instrumentation,
interventions novel one field research novel broad sense? refinement,
improvement, new application theoretical concepts, approaches methodologies,
instrumentation, interventions proposed? the proposed research innovation and yet offer reasonable potential for concrete
applications interest and value CDC?
Does the project have the potential increase efficiency lead costs savings?
Approach
Are the overall strategy, methodology, and analyses well-reasoned and appropriate
accomplish the specific aims the project? Are potential problems, alternative strategies, and
benchmarks for success presented? the project the early stages development, will the
strategy establish feasibility and will particularly risky aspects managed? the project involves clinical research, are there plans for protection human subjects
from research risks, and inclusion minorities and members both sexes/genders, well the inclusion children, justified terms the scientific goals and research strategy
proposed?
Environment
Will the scientific environment which the work will done contribute the probability
success? Are the institutional support, equipment and other physical resources available the
investigators adequate for the project proposed? Will the project benefit from unique features the scientific environment, subject populations, collaborative arrangements?
Does the applicant describe how the proposed work will relate other programs
sponsored the agency, which are already place planned support strengthen
disease surveillance, laboratory systems, emergency response and workforce
development?
Does the project utilize critical partnerships collaborations? Does the project support
key stakeholder involvement throughout the research process?
Does the project utilize critical partnerships collaborations including the Ministry
Health, Ministry Agriculture, with laboratory capacity including accredited
national reference laboratories? Additional Review Criteria applicable for the project proposed, reviewers will evaluate the following additional items
while determining scientific and technical merit, and providing overall impact/priority
score, but will not give separate scores for these items.
Protections for Human Subjects the research involves human subjects but does not involve one the six categories
research that are exempt under CFR Part 46, the committee will evaluate the justification for
involvement human subjects and the proposed protections from research risk relating their
participation according the following five review criteria: risk subjects, adequacy
protection against risks, potential benefits the subjects and others, importance the
knowledge gained, and data and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one more the six
categories research that are exempt under CFR Part 46, the committee will evaluate: the
justification for the exemption, human subjects involvement and characteristics, and
sources materials. For additional information review the Human Subjects section,
please refer the HHS/CDC Requirements under AR-1 Human Subjects Requirements
(https://www.cdc.gov/grants/additionalrequirements/ar-1.html). your proposed research involves the use human data and/or biological specimens, you must
provide justification for your claim that human subjects are involved the Protection
Human Subjects section the Research Plan.
Inclusion Women, Minorities, and Children
When the proposed project involves clinical research, the committee will evaluate the proposed
plans for inclusion minorities and members both genders, well the inclusion
children. For additional information review the Inclusion section, please refer the policy the Inclusion Women and Racial and Ethnic Minorities Research
(https://www.cdc.gov/maso/Policy/Policy_women.pdf and the policy the Inclusion
Persons Under Research (https://www.cdc.gov/maso/Policy/policy496.pdf).
Vertebrate Animals
The committee will evaluate the involvement live vertebrate animals part the scientific
assessment according the following five points: proposed use the animals, and species,
strains, ages, sex, and numbers used; justifications for the use animals and for the
appropriateness the species and numbers proposed; adequacy veterinary care;
procedures for limiting discomfort, distress, pain and injury that which unavoidable the
conduct scientifically sound research including the use analgesic, anesthetic, and
tranquilizing drugs and/or comfortable restraining devices; and methods euthanasia and
reason for selection not consistent with the AVMA Guidelines Euthanasia. For additional
information review the Vertebrate Animals section, please refer the Worksheet for
Review the Vertebrate Animal Section (https://grants.nih.gov/grants/olaw/VASchecklist.pdf).
Biohazards
Reviewers will assess whether materials procedures proposed are potentially hazardous
research personnel and/or the environment, and needed, determine whether adequate
protection proposed.
Dual Use Research Concern
Reviewers will identify whether the project involves one the agents toxins described the Government Policy for the Institutional Oversight Life Sciences Dual Use Research
Concern, and, so, whether the applicant has identified IRE assess the project
for DURC potential and develop mitigation strategies needed.
For more information about this Policy and other policies regarding dual use research
concern, visit the U.S. Government Science, Safety, Security (S3) website
at: http://www.phe.gov/s3/dualuse. Tools and guidance for assessing DURC potential may
found at: http://www.phe.gov/s3/dualuse/Pages/companion-guide.aspx. Additional Review Considerations applicable for the project proposed, reviewers will consider each the following items, but
will not give scores for these items, and should not consider them providing overall
impact/priority score.
Applications from Foreign Organizations
Reviewers will assess whether the project presents special opportunities for furthering
research programs through the use unusual talent, resources, populations,
environmental conditions that exist other countries and either are not readily available
the United States augment existing U.S. resources.
Resource Sharing Plan(s)
HHS/CDC policy requires that recipients grant awards make research resources and data
readily available for research purposes qualified individuals within the scientific community
after publication. Please see: https://www.cdc.gov/grants/additionalrequirements/ar-25.html
New additional requirement: CDC requires recipients for projects and programs that involve
data collection generation data with federal funds develop and submit Data
Management Plan (DMP) for each collection public health data.
Investigators responding this Notice Funding Opportunity should include
detailed DMP the Resource Sharing Plan(s) section the PHS 398 Research Plan
Component the application. The AR-25 outlines the components DMP and provides
additional information for investigators regarding the requirements for data accessibility,
storage, and preservation.
The DMP should developed during the project planning phase prior the initiation
collecting generating public health data and will submitted with the application. The
submitted DMP will evaluated for completeness and quality the time submission.
The DMP should include, minimum, description the following:
Type data produced the proposed project;
Mechanisms for providing access and sharing the data (including provisions for the
protection privacy, confidentiality, security, intellectual property, other rights);
Use data standards that ensure all released data have appropriate documentation that
describes the method collection, what the data represent, and potential limitations for use;
and
Plans for archiving and long-term preservation the data, explaining why long-term
preservation and access are not justified.
Applications submitted without the required DMP may deemed ineligible for award unless
submission DMP deferred later period depending the type award, which case,
funding restrictions may imposed pending submission and evaluation.
Budget and Period Support
Reviewers will consider whether the budget and the requested period support are fully
justified and reasonable relation the proposed research. The applicant can obtain guidance
for completing detailed justified budget the CDC website, the following Internet address:
http://www.cdc.gov/grants/interestedinapplying/applicationresources.html
The budget can include both direct costs and indirect costs allowed.
Indirect costs could include the cost collecting, managing, sharing and preserving data.
Indirect costs grants awarded foreign organizations and foreign public entities and
performed fully outside the territorial limits the U.S. may paid support the costs
compliance with federal requirements fixed rate eight percent modified total direct
costs exclusive tuition and related fees, direct expenditures for equipment, and subawards
excess $25,000. Negotiated indirect costs may paid the American University, Beirut,
and the World Health Organization.
Indirect costs training grants are limited fixed rate eight percent MTDC exclusive tuition and related fees, direct expenditures for equipment, and sub-awards excess
$25,000. requesting indirect costs the budget based federally negotiated rate, copy the
indirect cost rate agreement required. Include copy the current negotiated federal indirect
cost rate agreement cost allocation plan approval letter. Review and Selection Process
Applications will evaluated for scientific and technical merit appropriate peer review
group, accordance with CDC peer review policy and procedures, using the stated review
criteria. part the scientific peer review, all applications:
Will undergo selection process which only those applications deemed have the
highest scientific and technical merit (generally the top half applications under
review), will discussed and assigned overall impact/priority score.
Will receive written critique.
Applications will assigned the appropriate HHS/CDC Center, Institute, Office.
Applications will compete for available funds with all other recommended applications
submitted response this NOFO. Following initial peer review, recommended applications
will receive second level review. The following will considered making funding
decisions:
Scientific and technical merit the proposed project determined scientific peer
review.
Availability funds.
Relevance the proposed project program priorities.
Review risk posed applicants.
Prior making Federal award, CDC required U.S.C. 3321 and U.S.C. 2313
review information available through any OMB-designated repositories government-wide
eligibility qualification financial integrity information appropriate. See also suspension
and debarment requirements CFR parts 180 and 376. accordance U.S.C. 2313, CDC required review the non-public segment the OMBdesignated integrity and performance system accessible through SAM (currently the
Federal Recipient Performance and Integrity Information System (FAPIIS)) prior making
Federal award where the Federal share expected exceed the simplified acquisition
threshold, defined U.S.C. 134, over the period performance. minimum, the
information the system for prior Federal award recipient must demonstrate satisfactory
record executing programs activities under Federal grants, cooperative agreements,
procurement awards; and integrity and business ethics. CDC may make Federal award
recipient who does not fully meet these standards, determined that the information not
relevant the current Federal award under consideration there are specific conditions that
can appropriately mitigate the effects the non-Federal entitys risk accordance with CFR 75.207.
CDC framework for evaluating the risks posed applicant may incorporate results the
evaluation the applicants eligibility the quality its application. determined that
Federal award will made, special conditions that correspond the degree risk assessed
may applied the Federal award. The evaluation criteria described this Notice
Funding Opportunity. evaluating risks posed applicants, CDC will use risk-based approach and may consider
any items such the following:
(1) Financial stability;
(2) Quality management systems and ability meet the management standards prescribed
this part;
(3) History performance. The applicants record managing Federal awards, prior
recipient Federal awards, including timeliness compliance with applicable reporting
requirements, conformance the terms and conditions previous Federal awards, and
applicable, the extent which any previously awarded amounts will expended prior
future awards;
(4) Reports and findings from audits performed under subpart CFR the reports and
findings any other available audits; and
(5) The applicants ability effectively implement statutory, regulatory, other requirements
imposed non-Federal entities.
CDC must comply with the guidelines government-wide suspension and debarment CFR part 180, and require non-Federal entities comply with these provisions. These
provisions restrict Federal awards, subawards and contracts with certain parties that are
debarred, suspended otherwise excluded from ineligible for participation Federal
programs activities. Anticipated Announcement and Award Dates
After the peer review the application completed, the PD/PI will able access his her
Summary Statement (written critique) and other pertinent information via the eRA Commons.
Section VI. Award Administration Information Award Notices
Any applications awarded response this NOFO will subject the DUNS, SAM
Registration, and Transparency Act requirements. the application under consideration for
funding, HHS/CDC will request just-in-time information from the applicant described
the HHS Grants Policy Statement
(https://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf). formal notification the form Notice Award (NoA) will provided the applicant
organization for successful applications. The NoA signed the Grants Management Officer
the authorizing document and will sent via email the grantee business official.
Recipient must comply with any funding restrictions described Section IV.11. Funding
Restrictions. Selection application for award not authorization begin performance.
Any costs incurred before receipt the NoA are the recipients risk. These costs may
allowable expanded authority, but only authorized CDC. CDC Administrative Requirements
Overview Terms and Conditions Award and Requirements for Specific Types
Grants
Administrative and National Policy Requirements, Additional Requirements (ARs) outline the
administrative requirements found CFR Part and the HHS Grants Policy Statement and
other requirements mandated statute CDC policy. Recipients must comply with
administrative and national policy requirements appropriate. For more information the
Code Federal Regulations, visit the National Archives and Records
Administration: http://www.access.gpo.gov/nara/cfr/cfr-table- search.html.
Specific requirements that apply this NOFO are the following: Additional Policy Requirements
The following are additional policy requirements relevant this NOFO:
HHS Policy Promoting Efficient Spending: Use Appropriated Funds for Conferences
and Meetings, Food, Promotional Items and Printing Publications This policy supports the
Executive Order Promoting Efficient Spending (EO 13589), the Executive Order
Delivering and Efficient, Effective, and Accountable Government (EO 13576) and the Office
Management and Budget Memorandum Eliminating Excess Conference Spending and
Promoting Efficiency Government (M-35-11). This policy apply all new obligations and
all funds appropriated Congress. For more information, visit the HHS website
at: https://www.hhs.gov/grants/contracts/contract-policies-regulations/efficientspending/index.html.
Federal Funding Accountability and Transparency Act 2006 Federal Funding
Accountability and Transparency Act 2006 (FFATA), P.L. 109 282, amended section
6202 P.L. 110 252, requires full disclosure all entities and organizations receiving Federal
funds including grants, contracts, loans and other assistance and payments through single,
publicly accessible website, www.usaspending.gov. For the full text the requirements, please
review the following website: https://www.fsrs.gov/.
Plain Writing Act The Plain Writing Act 2010, Public Law 111-274 was signed into law
October 13, 2010. The law requires that federal agencies use clear Government communication
that the public can understand and use and requires the federal government write all new
publications, forms, and publicly distributed documents clear, concise, well-organized
manner. For more information this law,
to: http://www.plainlanguage.gov/plLaw/index.cfm.
Pilot Program for Enhancement Employee Whistleblower Protections All applicants will subject term and condition that applies the terms CFR section 3.908 the award
and requires that grantees inform their employees writing (in the predominant native
language the workforce) employee whistleblower rights and protections under U.S.C.
4712.
Copyright Interests Provision This provision intended ensure that the public has access
the results and accomplishments public health activities funded CDC. Pursuant
applicable grant regulations and CDC Public Access Policy, Recipient agrees submit into
the National Institutes Health (NIH) Manuscript Submission (NIHMS) system electronic
version the final, peer-reviewed manuscript any such work developed under this award
upon acceptance for publication, made publicly available later than months after the
official date publication. Also the time submission, Recipient and/or the Recipient
submitting author must specify the date the final manuscript will publicly accessible
through PubMed Central (PMC). Recipient and/or Recipient submitting author must also post
the manuscript through PMC within twelve (12) months the publishers official date final
publication; however the author strongly encouraged make the subject manuscript available soon possible. The recipient must obtain prior approval from the CDC for any exception
this provision.
The authors final, peer-reviewed manuscript defined the final version accepted for journal
publication, and includes all modifications from the publishing peer review process, and all
graphics and supplemental material associated with the article. Recipient and its submitting
authors working under this award are responsible for ensuring that any publishing copyright
agreements concerning submitted articles reserve adequate right fully comply with this
provision and the license reserved CDC. The manuscript will hosted both PMC and the
CDC Stacks institutional repository system. progress reports for this award, recipient must
identify publications subject the CDC Public Access Policy using the
applicable NIHMS identification number for three (3) months after the publication date
and the PubMed Central identification number (PMCID) thereafter.
Language Access for Persons with Limited English Proficiency Recipients federal
financial assistance from HHS must administer their programs compliance with federal civil
rights law. This means that recipients HHS funds must ensure equal access their programs
without regard person race, color, national origin, disability, age and, some
circumstances, sex and religion. This includes ensuring your programs are accessible persons
with limited English proficiency. Recipients federal financial assistance must take the
reasonable steps provide meaningful access their programs persons with limited English
proficiency.
Dual Use Research Concern September 24, 2014, the Government Policy for the
Institutional Oversight Life Sciences Dual Use Research Concern was released. Grantees
(foreign and domestic) receiving CDC funding after September 24, 2015 are subject
this policy. Research funded CDC involving the agents toxins named the policy, must reviewed determine involves one more the listed experimental effects and so,
whether meets the definition DURC. This review must completed Institutional
Review Entity (IRE) identified the funded institution.
Recipients also must establish Institutional Contact for Dual Use Research (ICDUR). The
award recipient must maintain records institutional DURC reviews and completed risk
mitigation plans for the term the research grant, cooperative agreement contract plus three
years after its completion, but less than eight years, unless shorter period required law regulation. project determined DURC, risk/benefit analysis must completed. CDC will
work collaboratively with the award recipient develop risk mitigation plan that the CDC
must approve. The USG policy can found http://www.phe.gov/s3/dualuse.
Non-compliance with this Policy may result suspension, limitation, restriction termination USG funding, loss future USG funding opportunities for the non-compliant USGfunded research project and USG funds for other life sciences research the institution,
consistent with existing regulations and policies governing USG funded research, and may
subject the institution other potential penalties under applicable laws and regulations.
Data Management Plan(s)
CDC requires that all new collections public health data include Data Management Plan
(DMP). For purposes this announcement, public health data means digitally recorded
factual material commonly accepted the scientific community basis for public health
findings, conclusions, and implementation.
This new requirement ensures that CDC compliance with the following; Office
Management and Budget (OMB) memorandum titled Open Data Policy
Managing Information Asset (OMB M-13-13); Executive Order 13642 titled Making
Open and Machine Readable the New Default for Government Information and the Office
Science and Technology Policy (OSTP) memorandum titled Increasing Access the Results Federally Funded Scientific Research (OSTP Memo).
The AR-25 https://www.cdc.gov/grants/additionalrequirements/ar-25.html outlines the
components DMP and provides additional information for investigators regarding the
requirements for data accessibility, storage, and preservation.
Certificates Confidentiality: Institutions and investigators are responsible for determining
whether research they conduct subject Section 301(d) the Public Health Service (PHS)
Act. Section 301(d), amended Section 2012 the 21st Century Cures Act, P.L. 114-255
(42 U.S.C. 241(d)), states that the Secretary shall issue Certificates Confidentiality
(Certificates) persons engaged biomedical, behavioral, clinical, other research activities which identifiable, sensitive information collected. furtherance this provision, CDC
supported research commenced ongoing after December 13, 2016 which identifiable,
sensitive information collected, defined Section 301(d), deemed issued Certificate
and therefore required protect the privacy individuals who are subjects such research.
Certificates issued this manner will not issued separate document, but are issued
application this term and condition this award. See Additional Requirement ensure
compliance with this term and condition. The link the full text at:
https://www.cdc.gov/grants/additionalrequirements/ar-36.html. Cooperative Agreement Terms and Conditions
The following special terms award are addition to, and not lieu of, otherwise applicable.
U.S. Office Management and Budget (OMB) administrative guidelines, U.S. Department
Health and Human Services (DHHS) grant administration regulations CFR Part 75, and
other HHS, PHS, and CDC grant administration policies.
The administrative and funding instrument used for this program will the cooperative
agreement, assistance mechanism (rather than acquisition mechanism), which
substantial CDC programmatic involvement with the recipients anticipated during the
performance the activities. Under the cooperative agreement, the HHS/CDC purpose
support and stimulate the recipients activities involvement and otherwise working jointly
with the award recipients partnership role; CDC Project Officers are not assume
direction, prime responsibility, dominant role the activities. Consistent with this concept,
the dominant role and prime responsibility resides with the recipients for the project whole,
although specific tasks and activities may shared among the recipients and HHS/CDC
defined below.
The PD(s)/PI(s) will have the primary responsibility for:
Complying with the responsibilities for the Extramural Investigators described
the Policy Public Health Research and Nonresearch Data Management and
Access https://www.cdc.gov/grants/additionalrequirements/ar-25.html
CDC staff has substantial programmatic involvement that above and beyond the normal
stewardship role awards, described below:
Assisting the PI, needed, complying with the Investigator responsibilities
described the Policy Public Health Research and Nonresearch Data
Management and Access https://www.cdc.gov/grants/additionalrequirements/ar-25
.html
Recipient will retain custody and have primary rights the data and software
developed under these awards, subject Government rights access consistent with
current DHHS, PHS, and CDC policies. Reporting
Recipients will required complete Research Performance Progress Report (RPPR) eRA
Commons least annually (see https://grants.nih.gov/grants/rppr/index.htm;
https://grants.nih.gov/grants/forms/report_on_grant.htm) and financial statements required
the HHS Grants Policy Statement. final progress report, invention statement, equipment inventory list and the expenditure data
portion the Federal Financial Report are required for closeout award, described
the HHS Grants Policy Statement.
Although the financial plans the HHS/CDC CIO(s) provide support for this program, awards
pursuant this funding opportunity depend upon the availability funds, evidence
satisfactory progress the recipient (as documented required reports) and the determination
that continued funding the best interest the Federal government.
The Federal Funding Accountability and Transparency Act 2006 (Transparency Act),
includes requirement for recipients Federal grants report information about firsttier subawards and executive compensation under Federal assistance awards issued FY2011 later.
Compliance with this law primarily the responsibility the Federal agency. However, two
elements the law require information collected and reported recipients: Information executive compensation when not already reported through the SAM
Registration; and Similar information all sub-awards/ subcontracts/ consortiums over $25,000.
requirement for recipients Federal grants report information about first-tier subawards and
executive compensation under Federal assistance awards issued FY2011 later.
All recipients applicable CDC grants and cooperative agreements are required report the
Federal Subaward Reporting System (FSRS) available www.fsrs.gov all subawards over
$25,000. See the HHS Grants Policy Statement
(https://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf). Submission Reports
The Recipient Organization must provide HHS/CDC with original, plus one hard copy the
following reports: Yearly Non-Competing Grant Progress Report, due 120 days before the end the current budget period. The RPPR form
(https://grants.nih.gov/grants/rppr/index.htm;
https://grants.nih.gov/grants/rppr/rppr_instruction_guide.pdf) completed the
eRA Commons website. The progress report will serve the non-competing
continuation application. Although the financial plans the HHS/CDC CIO(s) provide
support for this program, awards pursuant this funding opportunity are contingent
upon the availability funds, evidence satisfactory progress the recipient (as
documented required reports) and the determination that continued funding the
best interest the Federal government. Annual Federal Financial Report (FFR) 425
(https://grants.nih.gov/grants/forms/report_on_grant/federal_financial_report_ffr.htm)
required and must submitted through eRA Commons within days after the end
the calendar quarter which the budget period ends. final progress report, invention statement, equipment/inventory report, and the
final FFR are required days after the end the period performance. Content Reports Yearly Non-Competing Grant Progress Report: The grantees continuation
application/progress should include:
Description Progress during Annual Budget Period: Current Budget Period Progress
reported the RPPR form eRA Commons
(https://grants.nih.gov/grants/rppr/index.htm). Detailed narrative report for the current
budget period that directly addresses progress towards the Measures Effectiveness
included the current budget period proposal.
Research Aims: list each research aim/project Research Aim/Project: purpose, status (met, ongoing, and unmet), challenges, successes, and
lessons learned Leadership/Partnership: list project collaborations and describe the role external partners.
Translation Research page maximum). When relevant the goals the research
project, the should describe how the significant findings may used promote,
enhance, advance translation the research into practice may used inform
public health policy. This section should understandable variety audiences,
including policy makers, practitioners, public health programs, healthcare institutions,
professional organizations, community groups, researchers, and other potential users.
The should identify the research findings that were translated into public health
policy practice and how the findings have been may adopted public health
settings. Or, they cannot applied yet, this section should address which research
findings may translated, how these findings can guide future research related
activities, and recommendations for translation. relevant, describe how the results
this project could generalized populations and communities outside the study.
Questions consider preparing this section include:
How will the scientific findings translated into public health practice inform public
health policy?
How will the project improve effect the translation research findings into public
health practice inform policy?
How will the research findings help promote accelerate the dissemination,
implementation, diffusion improvements public health programs practices?
How will the findings advance guide future research efforts related activities?
Public Health Relevance and Impact page maximum). This section should address
improvements public health measured documented anticipated outcomes
from the project. The should consider how the findings the project relate beyond
the immediate study improved practices, prevention intervention techniques,
inform policy, use technology public health. Questions consider preparing
this section include:
How will this project lead improvements public health?
How will the findings, results, recommendations been used influence practices,
procedures, methodologies, etc.?
How will the findings, results, recommendations contributed documented
projected reductions morbidity, mortality, injury, disability, disease?
Current Budget Period Financial Progress: Status obligation current budget period
funds and estimate unobligated funds projected provided estimated FFR.
New Budget Period Proposal:
Detailed operational plan for continuing activities the upcoming budget period,
including updated Measures Effectiveness for evaluating progress during the
upcoming budget period. Report listed Research Aim/Project.
Project Timeline: Include planned milestones for the upcoming year (be specific and
provide deadlines).
New Budget Period Budget: Detailed line-item budget and budget justification for the
new budget period. Use the CDC budget guideline format.
Publications/Presentations: Include publications/presentations resulting from this CDC
grant only during this budget period. publication presentations have been made this stage the project, simply indicate Not applicable: publications
presentations have been made.
IRB Approval Certification: Include all current IRB approvals avoid funding
restriction your award. the research does not involve human subjects, then please
state so. Please provide copy the most recent local IRB and CDC IRB, applicable. any approval still pending time APR due date, indicate the status your
narrative.
Update Data Management Plan: The DMP considered living document that will
require updates throughout the lifecycle the project. Investigators should include any
updates the project data collection such changes initial data collection plan,
challenges with data collection, and recent data collected. Applicants should update
their DMP reflect progress issues with planned data collection and submit
required for each reporting period.
Additional Reporting Requirements:
https://era.nih.gov/docs/Commons_UserGuide.pdf Annual Federal Financial Reporting The Annual Federal Financial Report (FFR) 425
required and must submitted through eRA Commons within days after the end the
calendar quarter which the budget period ends. The FFR should only include those funds
authorized and disbursed during the timeframe covered the report. The final FFR must
indicate the exact balance unobligated funds and may not reflect
any unliquidated obligations. There must discrepancies between the
final FFR expenditure data and the Payment Management Systems (PMS) cash transaction
data.
Failure submit the required information timely manner may adversely affect the future
funding this project. the information cannot provided the due date, you are required submit letter explaining the reason and date which the Grants Officer will receive the
information.
The due date for final FFRs will continue days after the Period Performance end
date.
Recipients must submit closeout reports timely manner. Unless the Grants Management
Officer (GMO) the awarding Institute Center approves extension, recipients must
submit final FFR, final progress report, and Final Invention Statement and Certification within days the end grant period. Failure submit timely and accurate final reports may affect
future funding the organization awards under the direction the same Project
Director/Principal Investigator (PD/PI).
FFR (SF 425) instructions for CDC recipients are now available https://grants.nih.gov/grants/forms/report_on_grant/federal_financial_report_ffr.htm. For
further information, contact GrantsInfo@nih.gov. Additional resources concerning
the eFSR/FFR system, including User Guide and on-line demonstration, can found
the eRA Commons Support Page: https://grants.nih.gov/support/index.html
FFR Submission: The submission FFRs CDC will require organizations register
with eRA Commons (Commons) (https:// commons. era.nih.gov/ commons/). CDC
recommends that this one time registration process completed least weeks prior
the submittal date FFR submission.
Organizations may verify their current registration status running the List Commons
Registered Organizations query found at: https://era.nih.gov/registration_accounts.cfm.
Organizations not yet registered can https://commons.era.nih.gov/commons for
instructions. generally takes several days complete this registration process. This
registration independent Grants.gov and may done any time.
The individual designated the the application must also registered the Commons.
The must hold account and affiliated with the applicant organization. This registration
must done organizational official their delegate who already registered the
Commons. register PIs the Commons, refer the eRA Commons User Guide found
at: https://era.nih.gov/docs/Commons_UserGuide.pdf. Final Reports: Final reports should provide sufficient detail for CDC determine the
stated outcomes for the funded research have been achieved and the research findings resulted public health impact based the investment. The grantee final report should include:
Research Aim/Project Overview: The should describe the purpose and approach
the project, including the outcomes, methodology and related analyses. Include
discussion the challenges, successes and lessons learned. Describe the
collaborations/partnerships and the role each external partner.
Translation Research Findings: The should describe how the findings will
translated and how they will used inform policy promote, enhance advance
the impact public health practice. This section should understandable variety audiences, including policy makers, practitioners, public health
programs, healthcare institutions, professional organizations, community groups,
researchers and other potential end users. The should also provide discussion any
research findings that informed policy practice during the course the period
performance. applicable, describe how the findings could generalized and scaled
populations and communities outside the funded project.
Public Health Relevance and Impact: This section should address improvements
public health measured documented anticipated outcomes from the project. The should consider how the findings the project related beyond the immediate study
improved practices, prevention intervention techniques, informed policy,
technology systems improvements public health.
Publications; Presentations; Media Coverage: Include information regarding all
publications, presentations media coverage resulting from this CDC funded activity.
Please include any additional dissemination efforts that did will result from the
project.
Final Data Management Plan: Applicants must include updated final Data
Management Plan that describes the data collected, the location where the data
stored (example: repository), accessibility restrictions (if applicable), and the plans for
long term preservation the data.
Section VII. Agency Contacts encourage inquiries concerning this funding opportunity and welcome the opportunity
answer questions from potential applicants.
Application Submission Contacts
Grants.gov Customer Support (Questions regarding Grants.gov registration and submission,
downloading navigating forms)
Contact Center Phone: 800-518-4726
Email: support@grants.gov
Hours: hours day, days week; closed Federal holidays
eRA Commons Help Desk (Questions regarding eRA Commons registration, tracking
application status, post submission issues, FFR submission)
Phone: 301-402-7469 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: commons@od.nih.gov
Hours: Monday Friday, 7am 8pm U.S. Eastern Time
CDC Technical Information Management Section (TIMS)
Telephone 770-488-2700
Email: ogstims@cdc.gov
Hours: Monday Friday, 7am 4:30pm U.S. Eastern Standard Time
Scientific/Research Contact(s)
Daniel Duvall
DGHP country Director
Nigeria
dduvall@cdc.gov
Peer Review Contact(s)
Hylan Shoob, PhD
Scientific Review Officer
Center for Global Health
Extramural Research Program Office D-69, 1600, Clifton Road
Atlanta, 30033
Tel: 404-639-4796
E-mail: hshoob@cdc.gov
Financial/Grants Management Contact(s)
Angie Willard
Office Grants Services
Global Health Services Branch
Telephone: 770-488-2082
Email vhv5@cdc.gov
Section VIII. Other Information
Other CDC Notices Funding Opportunities can found www.grants.gov.
All awards are subject the terms and conditions, cost principles, and other considerations
described the HHS Grants Policy Statement.
Authority and Regulations
Awards are made under the authorization Sections the Public Health Service Act
amended and under the Code Federal Regulations.